Natus Medical Financial Ratios

Natus Medical Incorporated -- USA Stock  

USD 40.1  0.2  0.5%

Use fundamental data analysis to check out all available financial ratios of Natus Medical Incorp to find out if markets are presently mispricing the entity. We found thirty-six available fundamentals for Natus Medical which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Natus Medical Incorporated fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that Natus Medical Incorp has Number of Shares Shorted of 2.98 M, we recommend you check Natus Medical last-minute market performance to make sure the company can sustain itself down the road.Use Natus Medical to enhance returns of your portfolios. The stock experiences moderate upward volatility. Check odds of Natus Medical to be traded at $44.11 in 30 days

Natus Medical Incorp Valuation Over Time

Enterprise Value

Natus Medical Company Summary

Natus Medical competes with Edwards Lifesciences, Digirad, and DarioHealth Corp. It offers solutions and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders neuromuscular diseases and balance and mobility disorders. Natus Medical Incs product offerings include computerized neurodiagnostic systems for audiology neurology polysomnography and neonatology and software systems for managing and tracking disorders and diseases for public health laboratories. It offers neurology products such as diagnostic electroencephalography and longterm monitoring products electrodiagnostic monitoring products diagnostic polysomnography monitoring products diagnostic intraoperative monitoring products and transcranial Doppler products. Natus Medical Inc also offer newborn care products including hearing screening solutions to screen the hearing brain injury solutions to diagnose the severity of brain injury monitor the effectiveness of drug therapies detect seizure activity and monitor general neurological status and thermoregulation solutions to control the newborn environment including incubators and warmers. Its newborn care also comprise jaundice management solutions to measure bilirubin levels and treat jaundice diagnostic hearing assessment solutions to screen for or diagnose hearing loss or to identify abnormalities affecting the peripheral and central auditory nervous systems in patients of all ages balance and mobility systems to diagnose and assist in treating balance disorders and NicView video for families with babies in the neonatal intensive care unit. Natus Medical Inc serves hospitals clinics laboratories physicians nurses audiologists and governmental agencies. Natus Medical Incorporated was founded in 1987 and is headquartered in Pleasanton California.

Natus Medical Operating Margin vs Beta

Natus Medical Incorporated is number one stock in operating margin category among related companies. It is rated second in beta category among related companies totaling about  0.17  of Beta per Operating Margin. The ratio of Operating Margin to Beta for Natus Medical Incorporated is roughly  5.82 

Natus Medical Fundamentals

    
 Better Than Average     
    
 Worse Than Average Compare Natus Medical to competition
FundamentalsNatus MedicalPeer Average
Return On Equity4.58 % (15.17) %
Return On Asset3.02 % (15.64) %
Profit Margin4.23 % (5.5) %
Operating Margin6.23 % (10.91) %
Current Valuation1.33 B152.14 B
Shares Outstanding32.64 M1.43 B
Shares Owned by Insiders4 % 6.91 %
Shares Owned by Institutions97.47 % 18.37 %
Number of Shares Shorted2.98 M3.24 M
Price to Earning69.5 times40.69 times
Price to Book3.06 times14.44 times
Price to Sales2.94 times17.81 times
Revenue445.49 M9.85 B
Gross Profit234.93 M21.75 B
EBITDA48 M1.41 B
Net Income18.86 M517.71 M
Cash and Equivalents80.3 M3.89 B
Cash per Share2.47 times5.17 times
Total Debt109.5 M7.36 B
Debt to Equity25.6 % 0.72 %
Current Ratio3.33 times3.3 times
Book Value Per Share13.11 times13.64 times
Cash Flow from Operations50.01 M1.25 B
Short Ratio6.68 times2.09 times
Earnings Per Share0.58 times2.3 times
Price to Earnings To Growth1.07 times1.22 times
Number of Employees1.07 K10.67 K
Beta1.070.34
Market Capitalization1.31 B29.78 B
Total Asset479.5 M126.86 B
Retained Earnings149.41 M38.24 B
Working Capital164.25 M3.58 B
Current Asset241.36 M36.8 B
Current Liabilities77.11 M33.34 B
Z Score6.6708.73
< 4% 

Chance of Financial Distress

Natus Medical Incorporated has less than 4 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Details

Growth

Natus Medical Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth

Compare

Compare Natus Medical To Peers
James Hawkins CEO and President and Director
Robert Gunst Independent Chairman of the Board
More Executives

Opportunity Range

October 23, 2017 Opportunity Range